Company
Mersana Therapeutics, Inc. (0001442836)
Standardized SEC financial data for Mersana Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001442836 · Pharmaceutical Preparations.
Net margin
-170.9%
Revenue growth (YoY)
9.9%
Return on equity
727.6%
Free cash flow
-$82.5M
Debt / equity
-2.47×
Current ratio
2.19×
EPS (diluted)
$-0.56
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $42.1M | $828K | $43K | $26.6M | $36.9M | $40.5M |
| R&D expense |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $62.7M | $255.4M | $178.4M | $129.4M | $175.0M | $134.6M |
| Total current assets |
Cash flow
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$67.7M | -$74.7M | -$140.0M | -$49.4M | -$168.9M | -$82.3M |
| Capital expenditures |
Get 0001442836 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001442836/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001442836/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"